πŸ‡ΊπŸ‡Έ

US SEC Filing Intelligence

Β· daily

Global High-Priority Regulatory Events β€” April 24, 2026

Across 50 filings in the Global High Priority Market Events stream, dominant themes include robust revenue growth in select tech, energy, and financial firms (e.g., Reliance +9.8% YoY FY revenue, UP Fintech +56.3% YoY, Intel +7.2% YoY Q1), contrasted by margin pressures, losses, and operational challenges (e.g., Intel $3.1B operating loss, SHF Nasdaq delisting risk). M&A and capital market activity surged with mergers (Peoples Bancorp), offerings (Citius $5M raise), SPAC amendments (Willow Lane), and asset deals (Bio Essence $3.5M acquisition), while numerous Indian firms confirmed non-Large Corporate status under SEBI, signaling low debt burdens. Board/governance changes were prevalent (Wheels Up Delta designee, Easterly equity plan expansion), with proxy statements clustering for June 2026 AGMs. Portfolio-level trends show 12/20 financial reporters with YoY revenue growth averaging 25% but mixed PAT (e.g., Reliance +17.8%, GRAVITY -20.7%), highlighting resilience in consumer/digital segments amid energy weakness. Critical implications: monitor SPAC votes and delisting risks for short-term volatility; favor growth outperformers like UP Fintech amid PRC risks. Capital allocation leans toward buybacks/repurchases (First American $33.5M Q1, GoDaddy 10.2M shares), supporting shareholder returns despite selective dilution.

50 high priority 50 total filings
Β· daily

US Earnings Financial Results SEC Filings β€” April 24, 2026

Across 47 Q1 2026 earnings filings (primarily 10-Qs), mixed sentiment prevails with 45/47 rated mixed or negative, reflecting revenue growth averaging +8% YoY in large-caps (e.g., Intel +7%, LVS +25%, TI +19%) offset by profitability pressures from restructuring (Intel $4B charges), cost inflation (SkyWest fuel +59%), and impairments (Meritage $2.4M). Margin compression hits 18/47 companies (avg -100bps), particularly telecom (Charter video -9%) and homebuilders (Meritage -35% gross profit), while semiconductors (TI +19% rev, +31% NI) and energy services (Halliburton +129% NI) outperform. Capital allocation remains shareholder-friendly with buybacks/dividends in 35+ firms (e.g., Nasdaq $548M buybacks, LVS $746M), signaling management conviction amid 12/47 showing cash burn. Cash flow trends mixed: 22 improved YoY (e.g., Dow +$1B), 20 declined (e.g., Western Union -26%). Portfolio-level: Rotate from cyclicals (chemicals Dow -6% rev) to defensives (P&G +7% sales). Sector rotation opportunities in semis/energy; watch debt spikes (PMI short-term borrow +$5.5B). Actionable: Buyback-heavy names offer downside protection in volatile macro.

47 high priority 47 total filings
Β· daily

US SEC Trading Suspension Halt Orders β€” April 24, 2026

Across 7 US-listed microcap companies, a pervasive crisis of Nasdaq compliance dominates, with 6/7 filings citing Minimum Bid Price violations under Rule 5550(a)(2) after 30 consecutive business days below $1/share, signaling acute share price weakness and potential mass delistings to OTC markets. Triller Group faces an advanced delisting determination post-180-day cure failure and prior trading suspension (Dec 30, 2025-Apr 15, 2026), while Nuvve Holding risks imminent suspension on April 29, 2026, due to prior reverse splits (cumulative 250:1 ratio) rendering it ineligible for standard compliance periods. Mannatech stands out as the sole equity deficiency case ($5.223M deficit vs $2.5M requirement as of Dec 31, 2025), highlighting balance sheet deterioration without market value or net income alternatives. All filings carry negative sentiment (materiality 9-10/10), with no period-over-period financial improvements noted to support recovery; forward-looking plans (appeals, reverse splits) lack assurance of success. Portfolio-level pattern: No insider buying or capital returns (dividends/buybacks) amid board churn (SHF resignation/expansion) and litigation setbacks (SHF $3M registry at risk), implying low management conviction and high delisting cascade risk by Q4 2026. Market implications include liquidity evaporation, volatility spikes pre-suspension, and OTC discounts of 20-50% historically for similar cases.

7 high priority 7 total filings
Β· daily

US Corporate Distress Financial Stress SEC Filings β€” April 24, 2026

Across 48 filings in the USA Corporate Distress & Bankruptcy stream, a dominant theme is Nasdaq delisting risks from sub-$1 bid prices affecting 7 companies (Triller Group, SHF Holdings, Standard BioTools, Nuvve Holding, NexGel, Medicus Pharma, Zeo Energy), with compliance deadlines clustered around October 19-20, 2026, signaling widespread microcap distress. Counterbalancing this, 12 companies pursued liquidity enhancements via credit facility expansions or amendments (e.g., PDF Solutions +$30M to $70M revolver, Trane Technologies $1.5B new facility, AEVEX $375M total commitments), indicating proactive refinancing amid potential stress. Positive capital raises via equity offerings (e.g., Altimmune $211M net, Elmet IPO $109M net) and M&A (e.g., Peoples Bancorp acquiring Citizens National, Helix acquiring Hornbeck) suggest turnaround efforts, though mixed with litigation and defaults (Splash Beverage, urban-gro). No broad period-over-period revenue/margin trends available, but equity deficits (Mannatech -$5.2M vs $2.5M required) and contract terminations (Spire Global Can$71.8M potential lost) highlight deteriorating financials in outliers. Overall, portfolio-level pattern shows distress concentrated in Nasdaq-listed small caps, with credit actions providing near-term buffers but dilution risks from offerings; investors should prioritize monitoring delisting appeals and Q2 2026 catalysts for short opportunities.

48 high priority 48 total filings
Β· daily

US Executive Officer Management Changes SEC β€” April 24, 2026

Across 38 filings on US executive and director changes dated April 24, 2026, the dominant theme is routine governance refreshment with 20+ resignations (mostly for personal reasons, term limits, or retirements, none citing disagreements), balanced by 15+ appointments of experienced leaders in aerospace, finance, ops, and CPG sectors. Positive sentiments prevail in 10 cases (e.g., strategic board adds at Wheels Up and Woodward), while 22 are neutral; banking peers show strong shareholder approvals for directors and equity plans amid ChoiceOne's YoY net income turnaround from -$13.9M loss to +$13.7M despite slight QoQ dip. No widespread insider selling or pledges noted; capital allocation favors equity incentives (e.g., PNC's 28M-share plan approved at 96.6%). Portfolio-level patterns indicate small-cap/biotech instability (e.g., 3 Scorpius directors out) vs. large-cap stability, with interim C-suite roles signaling near-term transition risks but opportunities in permanent promotions (e.g., Lee Enterprises). Market implications: monitor for strategic shifts in partnerships (Wheels Up-Delta) and M&A (Trump Media), as changes enhance expertise without major disruptions.

38 high priority 38 total filings
Β· daily

US Corporate Board Director Changes SEC Filings β€” April 24, 2026

Across 37 SEC filings on USA Board Room Changes dated April 24, 2026, the dominant theme is executive and board stability with 18 appointments/nominations of experienced leaders (e.g., Delta CFO to Wheels Up board, aerospace expert to Woodward), offset by 22 routine resignations/retirements not citing disagreements, signaling low discord but potential continuity risks in biotechs and small caps. Annual meetings in financials (PNC, Jeld-Wen, 1st Source, Easterly, Fifth Third) showed overwhelming director support (avg 94-99% For votes), equity plan approvals (e.g., PNC 28M shares, Easterly +2.875M shares), and exec comp ratification >90%, indicating strong governance confidence amid no YoY declines in vote turnout (e.g., Jeld-Wen 85.64% vs prior implied stable). C-suite shifts include 6 CEO/CFO/COO changes (e.g., permanent CEOs at Lee Enterprises, ALT5 Sigma; interims at Nine Energy, American Shared, Trump Media), with comp uplifts like +22.6% salary at American Shared signaling retention urgency. No explicit insider selling patterns or financial deteriorations (e.g., stable D/E ratios implied in utilities like TVA), but forward-looking catalysts include M&A at Trump Media and proxy filings April 24 (Wheels Up). Sectorally, financials exhibit portfolio-level strength (6/8 high materiality >6/10), biotechs show churn (7/37 neutral resignations), and positive sentiment (9/37) correlates with strategic hires boosting transformation narratives. Overall, actionable now: overweight stable financial boards, monitor biotech interim voids for governance discounts.

37 high priority 37 total filings
Β· daily

US Merger & Acquisition SEC Filings β€” April 24, 2026

The 11 filings reveal a vibrant US M&A and takeover landscape dominated by SPAC activities (7/11 filings), including fresh IPOs, extensions, leadership transitions, and conditional listings, alongside four high-impact acquisitions in robotics, defense, pharma, and real estate finance. Key period-over-period trends highlight explosive growth in acquired entities: ASA Robotics revenue +213% YoY to HK$1.6M with margins expanding +5040 bps to 60.5%, Ondas backlog surging 160% to $457M pro forma, and Apollo CRE realizing $2.2B cash post-portfolio sale at a premium to trading levels. M&A completions (International Endeavors, Telomir, Ondas, Apollo) deliver strategic synergies, backlog boosts, and liquidity, signaling portfolio-level conviction in tech/defense/pharma sectors. SPAC maneuvers indicate ongoing deal hunting amid tight timelines, with extensions and amendments buying time for business combinations. Overall, bullish sentiment prevails (6/11 positive), pointing to actionable opportunities in post-merger entities and de-SPAC catalysts, though leadership churn and listing risks warrant caution.

11 high priority 11 total filings
Β· monthly

US Pre-Market SEC Filings Roundup β€” April 24, 2026

Overnight SEC filings reveal heavy institutional accumulation in tech megacaps like NVIDIA, Apple, Microsoft, and Alphabet across 20+ 13F-HR reports from firms including Ninety One entities, IFM Investors, Chicago Capital, totaling billions in AUM with concentrated positions signaling sustained bullish conviction. Among operating companies, 20-F annual reports show divergent performance: strong growth in UP Fintech (revenues +56.3% YoY to $612M, net income +179%), Hesai Group (+46% to RMB 3.03B), Ryde (+40% to S$12.5M), offset by declines in BingEx (-10.7% to RMB 3.99B), Gravity (+11.9% but operating profit -9.4%), and Medicure (revenue +32% but net loss widened to $7.1M on COGS surge). US financials mixed with First American revenues +16.2% YoY and net income +68.6%, Flagstar Bank Q1 net income turnaround to $21M (from Q1 2025 loss), Intel revenues +7.2% but deeper Q1 loss on restructuring. Capital allocation highlights include News Corp's $1B buyback continuation and First American's $33.5M repurchases/$56.2M dividends; no insider transactions noted across filings. Proxy season ramps up with June 2026 annual meetings for Palantir, VAALCO, Lucid, Comstock. Broader themes: AI/compute pivots (Allbirds $50M notes for NVIDIA GPUs), nuclear energy registration (X-Energy), SPAC activity; implications favor tech/energy longs amid mixed earnings recovery.

16 high priority 34 medium 50 total filings
Β· daily

Federal Construction & Infrastructure Contracts β€” April 23, 2026

This digest covers $528,988,381 in federal construction and infrastructure contract obligations across 6 awards from April 23, 2026 data, all civilian with 0 defense-related contracts. Dominant themes include VA hospital infrastructure (S.J. Amoroso $69.5M boiler plant, R.E.D. $39.8M upgrades) and DOI facilities/utilities (NW Construction $257.3M modification, Perini $42.3M wastewater). Highest-conviction bullish signal is S.J. Amoroso's $69.5M VA award (materiality 7/10) via full/open competition, signaling established position in institutional building construction. Key risk is pervasive high fixed-price execution across all contracts, with minimal outlays ($0 on four awards). Watch outlay progress and 2027 performance milestones amid neutral average signal strength of 4.8/10.

6 total filings
Β· daily

DHS Homeland Security Contracts β€” April 23, 2026

DHS awarded two civilian contracts totaling $129,158,323 in obligations during the April 23, 2026 period, with zero defense-related activity out of two awards. The dominant themes are U.S. Coast Guard construction via Whiting-Turner Contracting Company ($74,485,557 firm fixed-price delivery order) and FEMA preparedness training via Leidos, Inc. ($54,672,765 obligation, potential $85,196,410 ceiling). Both carry neutral signals (average strength 4.5/10), with the highest-conviction signal being steady revenue potential from Leidos' partially outlayed ($32,670,674) cost-plus contract. A key risk is Whiting-Turner's high execution risk under fixed-price terms with $0 outlayed to date on its June 2026-ending project. Investors should watch outlay progress and option exercises amid neutral sector momentum.

2 total filings
Β· daily

VA Healthcare & Services Contracts β€” April 23, 2026

The VA awarded $1,735,526,190 in healthcare and services contracts during the period, all civilian with 0/4 defense-related, dominated by Department of Veterans Affairs spending on IT hardware and hospital construction/infrastructure. Highest-conviction bullish signal is DELL FEDERAL SYSTEMS L.P.'s $1,590,136,261 award, representing 91.6% of total obligations and signaling strong VA tech procurement demand. S. J. AMOROSO CONSTRUCTION CO., LLC's $69,517,876 firm-fixed-price boiler plant contract adds construction momentum under full and open competition. Key risk is $0 outlays to date on the two largest construction awards (S. J. AMOROSO and R.E.D. CONSTRUCTION SERVICES, LLC), exposing high pricing risk amid multi-year performance periods.

4 total filings
Β· daily

HHS & Healthcare Contracts Intelligence β€” April 23, 2026

HHS contracts from April 23, 2026 total $277,577,764 in obligations, with 1/3 defense-related primarily through DLA Troop Support's $65M award for DoD pharmaceuticals. The dominant agency theme is HHS/BARDA biodefense and pharmaceutical procurement, led by Emergent BioDefense Operations Lansing LLC's $211.4M firm-fixed-price award for smallpox antiviral R&D. Highest-conviction signal is bullish on Emergent due to sole-source selection, $173.9M outlayed of $211.4M obligated, and potential $647.5M ceiling through 2032. Civilian HHS focus outweighs minor defense tie-in, but high pricing risk pervades all firm-fixed-price structures. Key watch item: Emergent options exercise and outlay progress beyond $173.9M toward 2028-10-01 current end.

3 total filings
Β· daily

New Federal Contractors β€” April 23, 2026

This one-day snapshot of 29 new federal contracts totals $3,864,631,168 in obligations, with only 1 defense-related award amid a dominant civilian agency focus (VA, HHS, Interior, NASA, DOL). Highest materiality goes to DELL FEDERAL SYSTEMS L.P.'s $1.59B VA contract (bullish, strength 7/10) and BOOZ ALLEN HAMILTON INC.'s $245M Interior IT delivery order (46% outlayed), signaling tech and construction strength in civilian spending. Emergent BioDefense's $211M HHS BARDA biodefense award (options to $647M) offers highest-conviction growth potential in biotech R&D. Key risk: 12 fixed-price contracts (e.g., S.J. AMOROSO's $70M VA boiler plant) carry high execution risk with many at $0 outlayed; watch option exercises and outlay progress amid CR uncertainty for Oct-Dec awards.

29 total filings
Β· daily

Significant Contract Modifications ($10M+) β€” April 23, 2026

These 29 significant contract modifications totaling $3,864,631,168 in obligations over April 23, 2026, are overwhelmingly civilian-focused (28/29 non-defense, with only DLA Troop Support's $65M HHS award for DoD pharmaceuticals qualifying as defense-related), highlighting steady but fragmented spending across HHS ($452M+), VA ($1.7B+ dominated by Dell), Interior ($544M+), and NASA. Dominant themes include healthcare services, construction/infrastructure, and IT/professional support, with no clear defense acceleration. Highest-conviction bullish signal is Dell Federal Systems L.P.'s $1.59B VA award, signaling massive tech exposure in veteran services. Key risk is execution on fixed-price contracts like Johnson Controls Government Systems LLC's $75.7M DOE ESPC ($0 outlayed, high risk over 25 years) and Whiting-Turner Contracting Company's $74.5M DHS build ($0 outlayed). Watch outlay progress on top awards amid potential CR uncertainty for future mods.

29 total filings
Β· daily

Contract Deobligations Alert β€” April 23, 2026

This Contract Deobligations Alert covers 29 contracts totaling $3,864,631,168 in obligations over April 23, 2026, with only 1 defense-related award amid 28 civilian contracts dominated by HHS ($392M+ across Emergent BioDefense, Maximus, Noridian, Pfizer), VA ($1.7B+ including Dell Federal $1.59B and S.J. Amoroso $69.5M), and Interior ($544M+ via Booz Allen $245M, NW Construction $257M). Highest-conviction bullish signal is Dell Federal Systems L.P.'s $1.59B VA award (materiality 8/10), underscoring tech/services durability despite deobligation context. Booz Allen Hamilton captures $285M across two Interior/DOE IT contracts, signaling consulting moat. Key risk: 12+ contracts at $0 outlayed (e.g., Whiting-Turner $74.5M DHS, S.J. Amoroso $69.5M VA) heighten execution uncertainty in fixed-price structures; watch outlay progress and option exercises amid CR vulnerability for recent awards.

29 total filings
Β· daily

Contract Option Exercises β€” April 23, 2026

This batch of 29 contract option exercises totals $3,864,631,168 in obligations, overwhelmingly civilian-focused with only 1/29 defense-related and the rest spanning VA, HHS, Interior, NASA, and DOL on IT services, construction, biodefense, and training. Dominant themes include VA and HHS commitments to infrastructure and health R&D, with highest-conviction bullish signal from DELL FEDERAL SYSTEMS L.P.'s $1,590,136,261 VA award underscoring tech durability in veteran services. Booz Allen Hamilton Inc. captures $285M across Interior ($244.96M) and DOE ($40.1M) for systems design and cyber support. Key risk is execution on fixed-price contracts like S.J. Amoroso Construction Co., LLC's $69.5M VA boiler plant with $0 outlayed, amid high pricing risks and partial funding on many awards.

29 total filings
Β· daily

Federal Professional Services Contracts β€” April 23, 2026

Two civilian federal professional services contracts totaling $150,688,734 in obligations were analyzed, with 0/2 defense-related, focusing on Department of Energy (DOE) and Securities and Exchange Commission (SEC) awards. JOHNSON CONTROLS GOVERNMENT SYSTEMS, LLC received the highest materiality award of $75,739,124 from DOE's SC Oak Ridge Office for long-term ESPC at Oak Ridge National Laboratory, while C2 ALASKA, LLC secured $74,949,609 from SEC for IPASS 2.0 support. Both carry neutral signals (avg 4.5/10 strength) due to firm fixed-price structures offering revenue stability but high execution risks, with $0 outlayed on Johnson Controls and $60,436,521 on C2 Alaska. Dominant theme is civilian engineering and consulting services with multi-year horizons to 2033 and 2032. Highest-conviction signal is potential long-term revenue for private entities, but no direct public market exposure. Key risk/watch: Monitor outlays and option exercises amid $0-$60M current spending and high pricing risks.

2 total filings
Β· daily

Federal IT & Cybersecurity Contracts β€” April 23, 2026

This digest covers six Federal IT & Cybersecurity contracts totaling $2,008,447,014 in obligations, all from civilian agencies (0/6 defense-related) including VA, Interior, Commerce, HHS, Energy, and VA again. Dominant themes are multi-year IT systems design and cyber support services across civilian departments, with VA leading at ~$1.626B combined. Highest-conviction bullish signal is DELL FEDERAL SYSTEMS L.P.'s $1.59B VA award, signaling strong demand for federal IT hardware/services. Booz Allen Hamilton appears twice ($285M total), reinforcing its civilian IT footprint. Key risk: Significant subawards (e.g., $17.9M in Booz Allen's DOE contract) and partial outlays (e.g., 46% in Interior award) reduce net prime revenue capture; watch outlay progress and option exercises amid Time & Materials pricing vulnerabilities.

6 total filings
Β· daily

NASA & Space Contracts Intelligence β€” April 23, 2026

NASA Goddard Space Flight Center obligated $178,975,557 across 1 contract (0 defense-related, fully civilian) to the nonprofit Association of Universities for Research in Astronomy, Inc. for the WFIRST Science Operations Center design phase, highlighting sustained civilian agency commitment to space R&D under a multi-year cost-plus-fixed-fee structure. The dominant theme is NASA's investment in space operations, tracking, and data acquisition R&D (PSC AR45), with $143,190,612 already outlayed and potential expansion to $204,955,978 via options through September 30, 2027. The highest-conviction signal is neutral (strength 3/10), indicating stable funding but no direct investment upside due to the recipient's nonprofit status. A key watch item is outlay progress beyond $143,190,612 and option exercises toward the $204,955,978 ceiling.

1 total filings
Β· daily

All HHS Contracts β€” April 23, 2026

HHS awarded $457,388,529 across 6 contracts in this period, with 1/6 defense-related (DLA Troop Support pharmaceuticals) and the rest civilian-focused on biodefense R&D, Medicare administration, and contact centers. Dominant themes center on BARDA biodefense (Emergent BioDefense $211.4M) and CMS Medicare services (Noridian $64.6M, Experian $44M), signaling steady civilian healthcare funding. Highest-conviction bullish signal is Emergent BioDefense Operations Lansing LLC's non-competed $211.4M firm fixed price BARDA contract for smallpox antiviral R&D, with $173.9M already outlayed and potential to $647.5M. Key risk is high pricing risk on fixed-price contracts like Emergent and DLA Troop Support's $65M future-dated award with $0 outlayed. Watch option exercises across multiple contracts, including Emergent toward $647.5M and Maximus Federal Services toward $91.5M.

6 total filings